Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdorninal sepsis

被引:32
作者
Gous, A
Lipman, J
Scribante, J
Tshukutsoane, S
Hon, H
Pinder, M
Mathivha, R
Verhoef, L
Stass, H
机构
[1] Univ Limpopo, Sch Pharm, ZA-0204 Medunsa, South Africa
[2] Univ Queensland, Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] Univ Witwatersrand, Dept Med, Intens Care Unit, Chris Hani Baragwanath Hosp, ZA-2001 Johannesburg, South Africa
[4] Bayer PTY & AG Germany, ZA-1600 Isando, South Africa
关键词
pharmacokinetics; antibiotics; fluoroquinolone; intensive care unit; volume of distribution;
D O I
10.1016/j.ijantimicag.2005.04.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study aimed to investigate whether fluid shifts alter ciprofloxacin pharmacokinetics in critically ill patients over time. Patients >= 18 years, with normal renal function, requiring intensive care treatment and parenteral antibiotics were enrolled. Group A (22 patients) included patients with documented intra-abdominal infections. Group B (18 patients) included patients with severe sepsis from other causes. All patients received intravenous ciprofloxacin 400 mg every 8 h infused over 60 min. Eight timed blood specimens were taken on days 0, 2 and 7. Ciprofloxacin plasma concentrations were determined using high performance liquid chromatography. There were no significant differences between the pharmacokinetics of the two groups or over time. Ciprofloxacin pharmacokinetics in critically ill patients do not change over time, and intra-abdominal sepsis does not alter ciprofloxacin pharmacokinetic parameters to a greater degree than sepsis from other causes in critically ill patients. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 21 条
[1]   Capillary electrophoresis with laser-induced fluorescence detection, an adequate alternative to high-performance liquid chromatography, for the determination of ciprofloxacin and its metabolite desethyleneciprofloxacin in human plasma [J].
Bannefeld, KH ;
Stass, H ;
Blaschke, G .
JOURNAL OF CHROMATOGRAPHY B, 1997, 692 (02) :453-459
[2]   Administration of antibiotics for pneumonia during respiratory failure: Reaching the target [J].
Brun-Buisson, C ;
Lemaire, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (09) :1554-1555
[3]   CIPROFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
CAMPOLIRICHARDS, DM ;
MONK, JP ;
PRICE, A ;
BENFIELD, P ;
TODD, PA ;
WARD, A .
DRUGS, 1988, 35 (04) :373-447
[4]   Aminoglycoside levels in critically ill surgical patients: The implications of physiologic criteria of sepsis [J].
Cornwell, EE ;
Belzberg, H ;
Berne, TV ;
Kern, JW ;
Henriques, G ;
Asensio, JA ;
Demetriades, D .
SOUTHERN MEDICAL JOURNAL, 1997, 90 (01) :33-36
[5]   Ciprofloxacin - An updated review of its pharmacology, therapeutic efficacy and tolerability [J].
Davis, R ;
Markham, A ;
Balfour, JA .
DRUGS, 1996, 51 (06) :1019-1074
[6]   TREATMENT OF SEVERE PNEUMONIA IN HOSPITALIZED-PATIENTS - RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING INTRAVENOUS CIPROFLOXACIN WITH IMIPENEM-CILASTATIN [J].
FINK, MP ;
SNYDMAN, DR ;
NIEDERMAN, MS ;
LEEPER, KV ;
JOHNSON, RH ;
HEARD, SO ;
WUNDERINK, RG ;
CALDWELL, JW ;
SCHENTAG, JJ ;
SIAMI, GA ;
ZAMECK, RL ;
HAVERSTOCK, DC ;
REINHART, HH ;
ECHOLS, RM ;
HELSMOORTEL, C ;
SOJASTRZEPA, D ;
SCHWAITZBERG, S ;
BAREFOOT, L ;
FEIN, AM ;
FEINSILVER, SH ;
ILOWITE, JS ;
CLARE, N ;
SCHULMAN, D ;
JONES, CB ;
GRIFFIN, RI ;
WROBEL, CW ;
BALLOW, CH ;
AMSDEN, G ;
MITCHELL, P ;
BESS, T ;
WILKINS, W ;
BROWN, RB ;
MCGEE, W ;
SAFFORD, MJ ;
LEVINE, DP ;
LERNER, SA ;
KRUSE, JA ;
BANDER, JJ ;
MCNEIL, P ;
MUNKARAH, M ;
SUMMER, WR ;
DEBOISBLANC, B ;
LEVISON, ME ;
KORZENIOWSKI, O ;
SIGLER, A ;
BALDASSARRE, J ;
WALSH, P ;
SAMEL, C ;
SESSLER, CN ;
POLK, RE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :547-557
[7]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[8]   Pulmonary disposition of vancomycin in critically ill patients [J].
Georges, H ;
Leroy, O ;
Alfandari, S ;
Guery, B ;
RousselDelvallez, M ;
Dhennain, C ;
Beaucaire, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (05) :385-388
[9]   GENERALIZED VASCULAR-PERMEABILITY AND PULMONARY-FUNCTION IN PATIENTS FOLLOWING SERIOUS TRAUMA [J].
GOSLING, P ;
SANGHERA, K ;
DICKSON, G .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1994, 36 (04) :477-481
[10]   Changes in vancomycin pharmacokinetics in critically ill infants [J].
Gous, AGS ;
Dance, MD ;
Lipman, J ;
Luyt, DK ;
Mathivha, R ;
Scribante, J .
ANAESTHESIA AND INTENSIVE CARE, 1995, 23 (06) :678-682